BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read more
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read moreScientists have discovered that a specific brain cell known as a ‘projection neuron’ has a central role to play in
Read moreEarly disease stages of multiple sclerosis (MS) are primarily characterized by immune cell infiltration of the central nervous system (CNS).
Read moreMedications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect
Read moreSelma Blair revealed she’s losing her eyelashes due to multiple sclerosis in a new Instagram post. Along with thanking friends
Read moreFor people with multiple sclerosis (MS), drinking around 290 calories per day of soda or other sugar-sweetened beverages, or the
Read moreTUESDAY, Feb. 26, 2019 — First symptoms and disease type are contributors to delays in multiple sclerosis (MS) diagnosis, according
Read moreDear Mayo Clinic: What causes multiple sclerosis, or MS, in people who don’t have it in their family? A: The
Read moreEast Hanover, NJ. October 17, 2018. Researchers have proposed a conceptual framework for examining the relationship between exercise and adaptive
Read moreLymphatic vessels that clean the brain of harmful material play a crucial role in the development and progression of multiple
Read more